A review of preclinical program development for evaluating injectable carriers for osteogenic factors.
Seeherman
Howard
H
Wyeth Research, Cambridge, MA 02140, USA. hseeherman@wyeth.com
Li
Rebecca
R
Wozney
John
J
D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000494:pharmacology*; D004195:Disease Models, Animal; D004337:Drug Carriers; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D017102:Fracture Healing / Q000187:drug effects*; D010012:Osteogenesis / Q000187:drug effects*; D016730:Program Development / Q000379:methods*; D011994:Recombinant Proteins / Q000494:pharmacology
D019485:Bone Morphogenetic Proteins; D004337:Drug Carriers; D011994:Recombinant Proteins